Libette Luce

Libette Luce is Vice President of Regulatory Affairs at Akero. She brings over 20 years of experience in the pharmaceutical industry with more than 15 years specializing in global regulatory affairs across multiple therapeutic areas including cardiovascular, dermatology, GI, metabolic and ophthalmic/retinal disease. Libette joins us from Innocoll Biotherapeutics, where she was VP, Head of Regulatory Affairs leading development and commercial global regulatory initiatives for the company’s product portfolio in the non-opioid pain management space. Prior to Innocoll, she was Executive Director of Global Regulatory Affairs at Bausch Health Companies, Inc. leading the management of product portfolios for Bausch’s business units, GI (Salix Pharmaceuticals), dermatology (Dow Pharmaceuticals) and ophthalmology (Bausch and Lomb, Inc.). She has also held global regulatory positions at Allergan (Abbvie), Forest Laboratories (Abbvie), Roche, and Schering-Plough (Merck). Libette holds a Master of Arts in Diplomacy and International Relations from Seton Hall University and a Bachelor of Arts in Political Science and International Studies from the University of Miami.